Researchers have discovered how a surface protein on brain cells, called Aplp1, can play a role in spreading material ...

The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people ...

Scientists have achieved a significant breakthrough in Parkinson’s research, developing a novel technique that can detect tiny brain clusters believed to trigger the debilitating disease. A hallmark ...

For neurologist and movement disorder specialist Dr. Jill Giordano Farmer, the fight against Parkinson’s isn’t just ...

On a special episode (first released on May 29, 2025) of The Excerpt podcast: Parkinson’s is a disease that afflicts an estimated 90,000 Americans every year. Dr. Lorenz Studer and Dr. Viviane Tabar ...

What happens in the brain when a person experiences the characteristic movement symptoms of Parkinson's disease? Researchers ...

The world's largest clinical trial for Parkinson’s disease has commenced, aiming to identify treatments that can slow or halt ...

An estimated 1.1 million Americans are living with Parkinson’s disease (PD), making it the second most common neurodegenerative disease after Alzheimer’s. “Parkinson’s is a disease in which neurons ...

Parkinson's disease (PD) is a widespread neurological ailment that is becoming more prevalent as the world's population ages. It is estimated that approximately 10 million people worldwide are ...

Parkinson's disease is fundamentally a breakdown in the functioning of a part of the brain called the basal ganglia, robbing ...

For decades, medical understanding of Parkinson’s disease focused exclusively on the brain, specifically the death of dopamine-producing neurons that control movement. This narrow view shaped ...

Skin conditions with Parkinson’s disease are common and manageable. By paying attention to these symptoms, patients can ...